化学&生物药
在化学&生物药领域，最新融资动态显示：Tarsus Pharmaceuticals Inc完成IPO后其他轮次融资，投资方为Vestal Point Capital、RTW Investments、ADAR1 Capital Management、Wellington Management、Bain Capital、TCGX。更多详细融资信息，可通过专题列表查阅。
2026-08-07
治疗药物研发商
医药研发/制造
化学&生物药
Vestal Point Capital;
Vestal Point Capital;
RTW Investments;
RTW Investments;
ADAR1 Capital Management;
Wellington Management;
Bain Capital;
TCGX;
2026-08-06
免疫疗法开发商
医药研发/制造
化学&生物药
Biomedical Advanced Research and Development Authority;
2026-08-06
创新药研发商
医药研发/制造
化学&生物药
Milky Way Investments;
Milky Way Investments;
葛兰素史克;
葛兰素史克;
ARCH Venture Partners;
Invus;
LoLa Capital Partners;
GV;
RA Capital;
Gates Frontier;
Bezos Expeditions;
2026-08-05
自身免疫性疾病领域创新疗法研发商
医药研发/制造
化学&生物药
泛大西洋投资;
泛大西洋投资;
Venrock Capital;
Venrock Capital;
BVF Partners;
赛诺菲;
Logos Capital;
Balyasny Asset;
Adage Capital Partners LP;
Dawn Biopharma;
Forbion Capital Partners;
诺和诺德;
Sofinnova Partners;
维梧资本;
RA Capital;